-
1
-
-
0142103746
-
Intravenous immune globulins: an update for clinicians
-
Knezevic-Maramica I., and Kruskall M.S. Intravenous immune globulins: an update for clinicians. Transfusion 43 10 (2003) 1460-1480
-
(2003)
Transfusion
, vol.43
, Issue.10
, pp. 1460-1480
-
-
Knezevic-Maramica, I.1
Kruskall, M.S.2
-
2
-
-
0142217518
-
Mechanisms of action of intravenous immunoglobulin in autoimmune and inflammatory diseases
-
Bayry J., Thirion M., Misra N., Thorenoor N., Delignat S., et al. Mechanisms of action of intravenous immunoglobulin in autoimmune and inflammatory diseases. Neurol. Sci. 24 Suppl 4 (2003) S217-S221
-
(2003)
Neurol. Sci.
, vol.24
, Issue.SUPPL. 4
-
-
Bayry, J.1
Thirion, M.2
Misra, N.3
Thorenoor, N.4
Delignat, S.5
-
3
-
-
0038377261
-
Mechanisms of action of intravenous immunoglobulin in autoimmune and inflammatory diseases
-
Bayry J., Misra N., Latry V., Prost F., Delignat S., et al. Mechanisms of action of intravenous immunoglobulin in autoimmune and inflammatory diseases. Transfus. Clin. Biol. 10 3 (2003) 165-169
-
(2003)
Transfus. Clin. Biol.
, vol.10
, Issue.3
, pp. 165-169
-
-
Bayry, J.1
Misra, N.2
Latry, V.3
Prost, F.4
Delignat, S.5
-
4
-
-
0021218493
-
Efficacy of intravenous immunoglobulin in primary humoral immunodeficiency disease
-
Cunningham-Rundles C., Siegal F.P., Smithwick E.M., Lion-Boule A., Cunningham-Rundles S., et al. Efficacy of intravenous immunoglobulin in primary humoral immunodeficiency disease. Ann. Intern. Med. 101 (1984) 435-439
-
(1984)
Ann. Intern. Med.
, vol.101
, pp. 435-439
-
-
Cunningham-Rundles, C.1
Siegal, F.P.2
Smithwick, E.M.3
Lion-Boule, A.4
Cunningham-Rundles, S.5
-
5
-
-
0021972020
-
Benefit of intravenous IgG replacement in hypogammaglobulinemic patients with chronic sinopulmonary disease
-
Roifman C.M., Lederman H.M., Lavi S., Stein L.D., Levison H., et al. Benefit of intravenous IgG replacement in hypogammaglobulinemic patients with chronic sinopulmonary disease. Am. J. Med. 79 (1985) 171-174
-
(1985)
Am. J. Med.
, vol.79
, pp. 171-174
-
-
Roifman, C.M.1
Lederman, H.M.2
Lavi, S.3
Stein, L.D.4
Levison, H.5
-
6
-
-
0036286074
-
Efficacy of intravenous immunoglobulin in the prevention of pneumonia in patients with common variable immunodeficiency
-
Busse P.J., Razvi S., and Cunningham-Rundles C. Efficacy of intravenous immunoglobulin in the prevention of pneumonia in patients with common variable immunodeficiency. J. Allergy Clin. Immunol. 109 6 (2002) 1001-1004
-
(2002)
J. Allergy Clin. Immunol.
, vol.109
, Issue.6
, pp. 1001-1004
-
-
Busse, P.J.1
Razvi, S.2
Cunningham-Rundles, C.3
-
7
-
-
2342634251
-
Immunoglobulin therapy to control lung damage in patients with common variable immunodeficiency
-
de Gracia J., Vendrell M., Alvarez A., Pallisa E., Rodrigo M.J., et al. Immunoglobulin therapy to control lung damage in patients with common variable immunodeficiency. Int. Immunopharmacol. 4 6 (2004) 745-753
-
(2004)
Int. Immunopharmacol.
, vol.4
, Issue.6
, pp. 745-753
-
-
de Gracia, J.1
Vendrell, M.2
Alvarez, A.3
Pallisa, E.4
Rodrigo, M.J.5
-
8
-
-
0035818044
-
Immunomodulation of autoimmune and inflammatory diseases with intravenous immune globulin
-
Kazatchkine M.D., and Kaveri S.V. Immunomodulation of autoimmune and inflammatory diseases with intravenous immune globulin. N. Engl. J. Med. 345 (2001) 747-755
-
(2001)
N. Engl. J. Med.
, vol.345
, pp. 747-755
-
-
Kazatchkine, M.D.1
Kaveri, S.V.2
-
9
-
-
0021702429
-
High-dose intravenous gammaglobulin for Kawasaki disease
-
Furusho K., Kamiya T., Nakano H., Kiyosawa N., Shinomiya K., et al. High-dose intravenous gammaglobulin for Kawasaki disease. Lancet 2 8411 (1984) 1055-1058
-
(1984)
Lancet
, vol.2
, Issue.8411
, pp. 1055-1058
-
-
Furusho, K.1
Kamiya, T.2
Nakano, H.3
Kiyosawa, N.4
Shinomiya, K.5
-
10
-
-
0019463420
-
High-dose intravenous gammaglobulin for idiopathic thrombocytopenic purpura in childhood
-
Imbach P., Barandun S., d'Apuzzo V., Baumgartner C., Hirt A., et al. High-dose intravenous gammaglobulin for idiopathic thrombocytopenic purpura in childhood. Lancet 1 8232 (1981) 1228-1231
-
(1981)
Lancet
, vol.1
, Issue.8232
, pp. 1228-1231
-
-
Imbach, P.1
Barandun, S.2
d'Apuzzo, V.3
Baumgartner, C.4
Hirt, A.5
-
11
-
-
0042667057
-
Prospective audit of adverse reactions occurring in 459 primary antibody-deficient patients receiving intravenous immunoglobulin
-
Immunology Nurses Study.
-
Brennan V.M., Salome-Bentley N.J., Chapel H.M., and Immunology Nurses Study. Prospective audit of adverse reactions occurring in 459 primary antibody-deficient patients receiving intravenous immunoglobulin. Clin. Exp. Immunol. 133 2 (2003) 247-251
-
(2003)
Clin. Exp. Immunol.
, vol.133
, Issue.2
, pp. 247-251
-
-
Brennan, V.M.1
Salome-Bentley, N.J.2
Chapel, H.M.3
-
12
-
-
0027522107
-
Adverse effects of intravenous immunoglobulin
-
Misbah S.A., and Chapel H.M. Adverse effects of intravenous immunoglobulin. Drug Saf. 9 4 (1993) 254-262
-
(1993)
Drug Saf.
, vol.9
, Issue.4
, pp. 254-262
-
-
Misbah, S.A.1
Chapel, H.M.2
-
13
-
-
0142178203
-
Risks associated with the use of intravenous immunoglobulin
-
Pierce L.R., and Jain N. Risks associated with the use of intravenous immunoglobulin. Transfus. Med. Rev. 17 4 (2003) 241-251
-
(2003)
Transfus. Med. Rev.
, vol.17
, Issue.4
, pp. 241-251
-
-
Pierce, L.R.1
Jain, N.2
-
14
-
-
0141721039
-
Therapy with intravenous immunoglobulins: complications and side-effects
-
Wittstock M., Benecke R., and Zettl U.K. Therapy with intravenous immunoglobulins: complications and side-effects. Eur. Neurol. 50 3 (2003) 172-175
-
(2003)
Eur. Neurol.
, vol.50
, Issue.3
, pp. 172-175
-
-
Wittstock, M.1
Benecke, R.2
Zettl, U.K.3
-
15
-
-
0033982566
-
Deep venous thrombosis of the arm after intravenous immunoglobulin infusion: case report and literature review of intravenous immunoglobulin-related thrombotic complications
-
Go R.S., and Call T.G. Deep venous thrombosis of the arm after intravenous immunoglobulin infusion: case report and literature review of intravenous immunoglobulin-related thrombotic complications. Mayo Clin. Proc. 75 (2000) 83-85
-
(2000)
Mayo Clin. Proc.
, vol.75
, pp. 83-85
-
-
Go, R.S.1
Call, T.G.2
-
16
-
-
0038623965
-
Intravenous immunoglobulin therapy results in post-infusional hyperproteinemia, increased serum viscosity, and pseudohyponatremia
-
Steinberger B.A., Ford S.M., and Coleman T.A. Intravenous immunoglobulin therapy results in post-infusional hyperproteinemia, increased serum viscosity, and pseudohyponatremia. Am. J. Hematol. 73 2 (2003) 97-100
-
(2003)
Am. J. Hematol.
, vol.73
, Issue.2
, pp. 97-100
-
-
Steinberger, B.A.1
Ford, S.M.2
Coleman, T.A.3
-
17
-
-
0028273062
-
High-dose intravenous immunoglobulin and serum viscosity: risk of precipitating thromboembolic events
-
(107)
-
Dalakas M.C. High-dose intravenous immunoglobulin and serum viscosity: risk of precipitating thromboembolic events. Neurology 44 (1994) 223-226 (107)
-
(1994)
Neurology
, vol.44
, pp. 223-226
-
-
Dalakas, M.C.1
-
18
-
-
0033692697
-
Nephrotoxicity of intravenous immunoglobulin
-
Levy J.B., and Pusey C.D. Nephrotoxicity of intravenous immunoglobulin. QJM 93 11 (2000) 751-755
-
(2000)
QJM
, vol.93
, Issue.11
, pp. 751-755
-
-
Levy, J.B.1
Pusey, C.D.2
-
19
-
-
0038240601
-
The clinical features of 16 cases of stroke associated with administration of IVIg
-
Caress J.B., Cartwright M.S., Donofrio P.D., and Peacock Jr. J.E. The clinical features of 16 cases of stroke associated with administration of IVIg. Neurology 60 11 (2003) 1822-1824
-
(2003)
Neurology
, vol.60
, Issue.11
, pp. 1822-1824
-
-
Caress, J.B.1
Cartwright, M.S.2
Donofrio, P.D.3
Peacock Jr., J.E.4
-
20
-
-
0036196289
-
Alteration of biochemical profiles after high-dose intravenous immunoglobulin administration in Kawasaki disease
-
Lee K.Y., Han J.W., Lee J.S., and Whang K.T. Alteration of biochemical profiles after high-dose intravenous immunoglobulin administration in Kawasaki disease. Acta Pediatr 91 (2002) 164-167
-
(2002)
Acta Pediatr
, vol.91
, pp. 164-167
-
-
Lee, K.Y.1
Han, J.W.2
Lee, J.S.3
Whang, K.T.4
-
21
-
-
0030753782
-
Effect of high-dose intravenous immunoglobulin on serum chemistry, hematology, and lymphocyte subpopulations: assessments based on controlled treatment trials in patients with neurological diseases
-
Koffman B.M., and Dalakas M.C. Effect of high-dose intravenous immunoglobulin on serum chemistry, hematology, and lymphocyte subpopulations: assessments based on controlled treatment trials in patients with neurological diseases. Muscle Nerve 20 9 (1997) 1102-1107
-
(1997)
Muscle Nerve
, vol.20
, Issue.9
, pp. 1102-1107
-
-
Koffman, B.M.1
Dalakas, M.C.2
-
22
-
-
0030443450
-
Effects of intravenous immune globulin on the peripheral lymphocyte phenotypes in Kawasaki disease
-
Lee H.K., Kim D.S., Noh G.W., and Lee K.Y. Effects of intravenous immune globulin on the peripheral lymphocyte phenotypes in Kawasaki disease. Yonsei Med. J. 37 5 (1996) 357-363
-
(1996)
Yonsei Med. J.
, vol.37
, Issue.5
, pp. 357-363
-
-
Lee, H.K.1
Kim, D.S.2
Noh, G.W.3
Lee, K.Y.4
-
23
-
-
0031032706
-
Modulation of lymphocyte and monocyte activity after intravenous immunoglobulin administration in vivo
-
Aukrust P., Muller F., Nordoy I., Haug C.J., and Froland S.S. Modulation of lymphocyte and monocyte activity after intravenous immunoglobulin administration in vivo. Clin. Exp. Immunol. 107 1 (1997) 50-56
-
(1997)
Clin. Exp. Immunol.
, vol.107
, Issue.1
, pp. 50-56
-
-
Aukrust, P.1
Muller, F.2
Nordoy, I.3
Haug, C.J.4
Froland, S.S.5
-
24
-
-
0032999936
-
In vivo modulation of cytokine synthesis by intravenous immunoglobulin
-
Sewell W.A., North M.E., Cambronero R., Webster A.D., and Farrant J. In vivo modulation of cytokine synthesis by intravenous immunoglobulin. Clin. Exp. Immunol. 116 3 (1999) 509-515
-
(1999)
Clin. Exp. Immunol.
, vol.116
, Issue.3
, pp. 509-515
-
-
Sewell, W.A.1
North, M.E.2
Cambronero, R.3
Webster, A.D.4
Farrant, J.5
-
25
-
-
0032149583
-
Metabolic and hematologic changes occurring after rapid intravenous infusion of gammaglobulin in patients with antibody deficiency syndromes
-
Costa-Carvalho B.T., Lin M., Solé D., Carneiro-Sampaiao M.M.S., Sorensen R.U., and Naspitz C.K. Metabolic and hematologic changes occurring after rapid intravenous infusion of gammaglobulin in patients with antibody deficiency syndromes. Rev. Paul. Med. 116 5 (1998) 1815-1820
-
(1998)
Rev. Paul. Med.
, vol.116
, Issue.5
, pp. 1815-1820
-
-
Costa-Carvalho, B.T.1
Lin, M.2
Solé, D.3
Carneiro-Sampaiao, M.M.S.4
Sorensen, R.U.5
Naspitz, C.K.6
-
26
-
-
0027731524
-
Elimination of infectious antigens and increase of IgG catabolism as possible mode of action of IVIg
-
Masson P.L. Elimination of infectious antigens and increase of IgG catabolism as possible mode of action of IVIg. J. Autoimmun. 6 (1993) 683-689
-
(1993)
J. Autoimmun.
, vol.6
, pp. 683-689
-
-
Masson, P.L.1
-
27
-
-
0033590571
-
Mechanism of intravenous immune globulin therapy in antibody-mediated autoimmune diseases
-
Yu Z., and Lennon V.A. Mechanism of intravenous immune globulin therapy in antibody-mediated autoimmune diseases. N. Engl. J. Med. 340 3 (1999) 227-228
-
(1999)
N. Engl. J. Med.
, vol.340
, Issue.3
, pp. 227-228
-
-
Yu, Z.1
Lennon, V.A.2
-
28
-
-
0035892141
-
Accelerated autoantibody clearance by intravenous immunoglobulin therapy: studies in experimental models to determine the magnitude and time course of the effect
-
Bleeker W.K., Teeling J.L., and Hack C.E. Accelerated autoantibody clearance by intravenous immunoglobulin therapy: studies in experimental models to determine the magnitude and time course of the effect. Blood 98 10 (2001) 3136-3142
-
(2001)
Blood
, vol.98
, Issue.10
, pp. 3136-3142
-
-
Bleeker, W.K.1
Teeling, J.L.2
Hack, C.E.3
-
29
-
-
0032572931
-
Intravenous immune globulin and pseudohyponatremia
-
Lawn N., Wijdicks E.F., and Burritt M.F. Intravenous immune globulin and pseudohyponatremia. N. Engl. J. Med. 339 9 (1998) 632
-
(1998)
N. Engl. J. Med.
, vol.339
, Issue.9
, pp. 632
-
-
Lawn, N.1
Wijdicks, E.F.2
Burritt, M.F.3
-
30
-
-
0037445605
-
Changes in serum macrophage-related factors in patients with chronic inflammatory demyelinating polyneuropathy caused by intravenous immunoglobulin therapy
-
Ochi K., Kohriyama T., Higaki M., Ikeda J., Harada A., et al. Changes in serum macrophage-related factors in patients with chronic inflammatory demyelinating polyneuropathy caused by intravenous immunoglobulin therapy. J. Neurol. Sci. 208 1-2 (2003) 43-50
-
(2003)
J. Neurol. Sci.
, vol.208
, Issue.1-2
, pp. 43-50
-
-
Ochi, K.1
Kohriyama, T.2
Higaki, M.3
Ikeda, J.4
Harada, A.5
-
31
-
-
0032860475
-
Inflammatory parameters and soluble cell adhesion molecules in Swedish children with Kawasaki disease: relationship to cardiac lesions and intravenous immunoglobulin treatment
-
Schiller B., and Elinder G. Inflammatory parameters and soluble cell adhesion molecules in Swedish children with Kawasaki disease: relationship to cardiac lesions and intravenous immunoglobulin treatment. Acta Paediatr. 88 8 (1999) 844-848
-
(1999)
Acta Paediatr.
, vol.88
, Issue.8
, pp. 844-848
-
-
Schiller, B.1
Elinder, G.2
-
32
-
-
0035660153
-
Intravenous immune globulin effects on serum-soluble CD5 levels in atopic dermatitis
-
Noh G., and Lozano F. Intravenous immune globulin effects on serum-soluble CD5 levels in atopic dermatitis. Clin. Exp. Allergy 31 12 (2001) 1932-1938
-
(2001)
Clin. Exp. Allergy
, vol.31
, Issue.12
, pp. 1932-1938
-
-
Noh, G.1
Lozano, F.2
-
33
-
-
0031836298
-
Intravenous immunoglobulin induced nephropathy: a complication of IVIG therapy
-
Ahsan N. Intravenous immunoglobulin induced nephropathy: a complication of IVIG therapy. J. Nephrol. 11 3 (1998) 157-161
-
(1998)
J. Nephrol.
, vol.11
, Issue.3
, pp. 157-161
-
-
Ahsan, N.1
-
34
-
-
0347651357
-
Intravenous immunoglobulin G and anti-D as therapeutic interventions in immune thrombocytopenic purpura
-
Blanchette V., and Carcao M. Intravenous immunoglobulin G and anti-D as therapeutic interventions in immune thrombocytopenic purpura. Transfus. Sci. 19 (1998) 279-288
-
(1998)
Transfus. Sci.
, vol.19
, pp. 279-288
-
-
Blanchette, V.1
Carcao, M.2
-
35
-
-
0037410194
-
Mechanism of action of IVIG and anti-D in ITP
-
Lazarus A.H., and Crow A.R. Mechanism of action of IVIG and anti-D in ITP. Transfus. Apheresis Sci. 28 3 (2003) 249-255
-
(2003)
Transfus. Apheresis Sci.
, vol.28
, Issue.3
, pp. 249-255
-
-
Lazarus, A.H.1
Crow, A.R.2
-
36
-
-
0035883092
-
Therapeutic efficacy of intravenous immunoglobulin preparations depends on the immunoglobulin G dimers: studies in experimental immune thrombocytopenia
-
Teeling J.L., Jansen-Hendriks T., Kuijpers T.W., de Haas M., van de Winkel J.G., et al. Therapeutic efficacy of intravenous immunoglobulin preparations depends on the immunoglobulin G dimers: studies in experimental immune thrombocytopenia. Blood 98 4 (2001) 1095-1099
-
(2001)
Blood
, vol.98
, Issue.4
, pp. 1095-1099
-
-
Teeling, J.L.1
Jansen-Hendriks, T.2
Kuijpers, T.W.3
de Haas, M.4
van de Winkel, J.G.5
-
37
-
-
0036264375
-
Intravenous immunoglobulin therapy induces neutrophil apoptosis in Kawasaki disease
-
Tsujimoto H., Takeshita S., Nakatani K., Kawamura Y., Tokutomi T., et al. Intravenous immunoglobulin therapy induces neutrophil apoptosis in Kawasaki disease. Clin. Immunol. 103 2 (2002) 161-168
-
(2002)
Clin. Immunol.
, vol.103
, Issue.2
, pp. 161-168
-
-
Tsujimoto, H.1
Takeshita, S.2
Nakatani, K.3
Kawamura, Y.4
Tokutomi, T.5
-
38
-
-
0025666414
-
CD4 and CD8 subpopulation changes during hig dose intravenous immunoglobulin treatment
-
Macey M.G., and Newland A.C. CD4 and CD8 subpopulation changes during hig dose intravenous immunoglobulin treatment. Br. J. Haematol. 76 (1990) 513-520
-
(1990)
Br. J. Haematol.
, vol.76
, pp. 513-520
-
-
Macey, M.G.1
Newland, A.C.2
-
39
-
-
0013591065
-
Immunoregulatory changes in Kawasaki disease
-
Jason J., Gregg L., Han A., Hu A., Inge K.L., et al. Immunoregulatory changes in Kawasaki disease. Clin. Immunol. Immunopathol. 84 3 (1997) 296-306
-
(1997)
Clin. Immunol. Immunopathol.
, vol.84
, Issue.3
, pp. 296-306
-
-
Jason, J.1
Gregg, L.2
Han, A.3
Hu, A.4
Inge, K.L.5
-
40
-
-
0037296040
-
Pooled human gammaglobulin modulates surface molecule expression and induces apoptosis in human B cells
-
Toyoda M., Pao A., Petrosian A., and Jordan S.C. Pooled human gammaglobulin modulates surface molecule expression and induces apoptosis in human B cells. Am. J. Transplant. 3 (2003) 156-166
-
(2003)
Am. J. Transplant.
, vol.3
, pp. 156-166
-
-
Toyoda, M.1
Pao, A.2
Petrosian, A.3
Jordan, S.C.4
-
41
-
-
0037204949
-
B cell antigen receptor signaling: roles in cell development and disease
-
Gauld S.B., Dal Porto M., and Cambier J.C. B cell antigen receptor signaling: roles in cell development and disease. Science 296 (2002) 1641-1642
-
(2002)
Science
, vol.296
, pp. 1641-1642
-
-
Gauld, S.B.1
Dal Porto, M.2
Cambier, J.C.3
-
42
-
-
0038487093
-
Analysis of changes in the percentage of B (CD19) and T (CD3) lymphocytes, subsets CD4, CD8 and their memory (CD45RO), and naive (CD45RA) T cells in children with immune and non-immune thyroid diseases
-
Bossowski A., Urban M., and Stasiak-Barmuta A. Analysis of changes in the percentage of B (CD19) and T (CD3) lymphocytes, subsets CD4, CD8 and their memory (CD45RO), and naive (CD45RA) T cells in children with immune and non-immune thyroid diseases. J. Pediatr. Endocrinol. Metab. 16 1 (2003) 63-70
-
(2003)
J. Pediatr. Endocrinol. Metab.
, vol.16
, Issue.1
, pp. 63-70
-
-
Bossowski, A.1
Urban, M.2
Stasiak-Barmuta, A.3
-
43
-
-
0034544489
-
Quantitative genetic variation in CD19 expression correlates with autoimmunity
-
Sato S., Hasegawa M., Fujimoto M., Tedder T.F., and Takehara K. Quantitative genetic variation in CD19 expression correlates with autoimmunity. J. Immunol. 165 11 (2000) 6635-6643
-
(2000)
J. Immunol.
, vol.165
, Issue.11
, pp. 6635-6643
-
-
Sato, S.1
Hasegawa, M.2
Fujimoto, M.3
Tedder, T.F.4
Takehara, K.5
|